BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6430305)

  • 1. Cardiac and haemodynamic effects of intravenous administrations of flunarizine in closed-chest anaesthetized mongrel dogs.
    Kubo K; Van de Water A; Wouters L; Xhonneux R; Reneman RS
    Arzneimittelforschung; 1984; 34(4):434-9. PubMed ID: 6430305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of (E)-1-[bis (4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl) piperazine dihydrochloride(flunarizine) on cerebral circulation].
    Kubo K; Karasawa A; Yamada K; Nito M; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1982 May; 79(5):383-400. PubMed ID: 7129248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilating effect of flunarizine in anesthetized dogs.
    Kato H; Kurihara J; Ishii K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):257-63. PubMed ID: 7224725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic studies with flunarizine, a calcium influx blocker.
    Gulati N; Huggel H; Gulati OP
    Arch Int Pharmacodyn Ther; 1983 May; 263(1):17-27. PubMed ID: 6615081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of flunarizine on cerebral venous outflow and cerebral oxygen consumption].
    Kubo K; Jageneau T
    Nihon Yakurigaku Zasshi; 1982 Jun; 79(6):529-41. PubMed ID: 7129242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects of lercanidipine in anaesthetized open-chest dogs.
    Sironi G; Montagna E; Greto L; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Mar; 46(3):256-61. PubMed ID: 8901145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excretion and metabolism of flunarizine in rats and dogs.
    Meuldermans W; Hendrickx J; Hurkmans R; Swysen E; Woestenborghs R; Lauwers W; Heykants J
    Arzneimittelforschung; 1983; 33(8):1142-51. PubMed ID: 6685491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and hemodynamic studies on flunarizine.
    Gulati N; Huggel H; Gulati OP
    Gen Pharmacol; 1983; 14(1):203-6. PubMed ID: 6826036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of flunarizine on nystagmus and cochlear blood flow].
    Shiozaki S; Kubo K; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):429-39. PubMed ID: 7160792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a calcium-antagonist (flunarizine) on the in vitro growth of B16 mouse melanoma cells.
    Sezzi ML; Zupi G; De Luca G; Materazzi M; Bellelli L
    Anticancer Res; 1984; 4(4-5):229-34. PubMed ID: 6091526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the new calcium antagonist monatepil on cardiac function and myocardial oxygen supply and demand in animals.
    Kataoka T; Nose I; Honda Y; Yamada T; Hatano N; Masuda Y; Hosoki K; Karasawa T
    Arzneimittelforschung; 1993 Dec; 43(12):1303-9. PubMed ID: 8141817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of verapamil, prenylamine, flunarizine and cinnarizine on coronary artery occlusion-induced arrhythmias in anaesthetized rats.
    Fagbemi O; Kane KA; McDonald FM; Parratt JR; Rothaul AL
    Br J Pharmacol; 1984 Sep; 83(1):299-304. PubMed ID: 6487894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The action of flunarizine and lidoflazine on isoprenaline induced cardiac lesions.
    Godfraind T; Khouri G; Sturbois X
    Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):330-2. PubMed ID: 7406590
    [No Abstract]   [Full Text] [Related]  

  • 16. The responses of the systemic and pulmonary circulations to intravenously administered clonidine in anaesthetized dogs.
    Järvensivu P; Timisjärvi J; Kettunen R
    Acta Physiol Scand Suppl; 1984; 537():23-30. PubMed ID: 6596860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aligeron on the cerebral venous outflow and cerebrospinal fluid pressure in dogs.
    Nikolova M; Nikolov R; Hadjiev D; Yancheva S
    Methods Find Exp Clin Pharmacol; 1981; 3(4):213-6. PubMed ID: 7278433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection with flunarizine against hypoxic-ischaemic damage of the rat cerebral cortex. A quantitative morphologic assessment.
    Van Reempts J; Borgers M; Van Dael L; Van Eyndhoven J; Van De Ven M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):76-88. PubMed ID: 6870389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a calcium-antagonist (flunarizine) on cancer cell movement and phagocytosis.
    Sezzi ML; De Luca G; Materazzi M; Bellelli L
    Anticancer Res; 1985; 5(3):265-71. PubMed ID: 4015040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ornipressin (POR 8)--effect on coronary blood circulation and the peripheral circulation. An animal experimental study].
    Veit S; Poethko C; Heidelmeyer CF; Brückner JB
    Anaesthesist; 1993 Sep; 42(9):597-604. PubMed ID: 8214531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.